BAYRYNEUTRAL

Gross Margin

61.0%

Higher than 34% of Healthcare sector peers

Updated 165h ago

Sector Performance

34th percentile

BAYRY

61.0%

Sector Median

68.9%

Sector Avg

-20.2%

📊

Deep Analysis

Bayer’s gross margin of 61.0% means that for every dollar of revenue, 61 cents remains after deducting the direct cost of producing its goods.

This metric places the company below the sector median of 68.9%, at the 37th percentile among healthcare peers, indicating that its cost structure is less efficient than most competitors. Trend data is not available; both the year-over-year and quarter-over-quarter changes are listed as N/A, and only a single historical value of 61.0% is provided, offering no insight into direction. Without a trend, the level alone suggests a downside risk relative to the sector average, but the absence of movement means there is no confirmation of worsening or improvement. The 61.0% gross margin is below the sector median, which could be a concern, but the lack of trend data makes it difficult to evaluate the trajectory. This metric supports the NEUTRAL verdict because the below-median margin is tempered by the inability to assess whether the gap is narrowing or widening.

Frequently Asked Questions

What does the Gross Margin tell investors about BAYRY?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does BAYRY's Gross Margin compare to its sector?

BAYRY's Gross Margin of 61.0% compares to a Healthcare sector median of 68.9%, placing it in the 34th percentile.

Who are BAYRY's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: BLUE (68.4%), AMGN (68.2%), TDOC (67.8%), TECH (66.9%), NTRA (64.8%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.